γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity
Anke Janssen1, Jose Villacorta Hidalgo2,3,4, Dennis X Beringer1
1Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Cancer Immunology Research
|February 6, 2020
Summary
Gamma delta T lymphocytes (γδ TILs) in breast cancer show a proinflammatory phenotype and potential antitumor activity. Engineered T cells expressing their T-cell receptors (TCRs) offer promise for adoptive cell therapies.
Area of Science:
- Immunology
- Oncology
Background:
- Gamma delta (γδ) T cells within human solid tumors are not well understood.
- Their role in breast cancer, specifically, requires further definition.
Purpose of the Study:
- To analyze the molecular and functional characteristics of T-cell receptors (TCRs) from tumor-infiltrating γδ T lymphocytes (γδ TILs) in breast cancer.
- To investigate the potential of these γδ TILs and their TCRs in mediating antitumor responses.
Main Methods:
- Analysis of T-cell receptors (TCRs) from archival breast cancer lesions.
- Molecular and functional characterization of tumor-infiltrating γδ T lymphocytes (γδ TILs).
- Reconstruction of matched Vδ2 TCRγ and TCRδ pairs using single-cell sequencing.
Main Results:
- The majority of γδ TILs exhibited a proinflammatory phenotype, with a minority expressing IL17.
- A higher proportion of Vδ2+ T cells was observed in breast cancer compared to other tumor types.
- γδ TIL-derived TCRs demonstrated reactivity against tumor cells, dependent on both TCRγ and TCRδ chains, independent of other innate immune receptors.
Conclusions:
- γδ TILs can mediate tumor reactivity through their unique γδ TCR pairs.
- Engineered T cells expressing γδ TIL-derived TCRs show potent antitumor reactivity against various cancer types.
- These findings suggest γδ TILs are a valuable resource for developing adoptive cell therapies.
Related Concept Videos
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
T Cell Activation and Clonal Selection
14.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.4K


